https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2022.973688/full
Background JAK (Janus kinases) inhibitors have been proposed as a promising treatment option for the coronavirus disease-2019 (COVID-19). However, the benefi...
janus kinasescoronavirus diseasefrontiersinhibitorspairwise